Shtetet e Bashkuara të Amerikës kanë vendosur të ndihmojnë Shqipërinë me 1.2 milionë dollar, për të fituar përballjen me koronavirusin.

Lajmin e bën të ditur ambasadorja e SHBA në Tiranë, Yuri Kim, e cila shkruan në “Twitter” se kjo ndihmë do të shkojë për përgatitjen e sistemeve laboratorike, aktivizimin dhe mbikëqyrjen e rasteve të reja të infektuar, ekspertët, etj.

“Fondi amerikan për të ndihmuar Shqipërinë të luftojë COVID-19 arrin në 1.2 milionë dollar, duke e çuar në 693 milionë dollarë ndihmën totale të SHBA për Shqipërinë në 20 vitet e fundit. Kjo shumë do të ndihmojë në përgatitjen e sistemeve laboratorike, aktivizimin dhe mbikëqyrjen e rasteve, mbështetjen e ekspertëve teknikë”, shkruan ambasadorja Kim.

Ambassador Yuri Kim

@USAmbAlbania

·

Apr 8

⁦

@SecPompeo

⁩: add’l $225 million for partners to fight #COVID19. This is on top of $274 million announced 3/26 - builds on >$140 billion in health assistance over the last 20 years. US will always meet global challenges with leadership & generosity.

Continuing U.S. Leadership in the Global COVID-19 Response Through Additional U.S. Foreign Assistance

PRESS STATEMENT

MICHAEL R. POMPEO, SECRETARY OF STATE

APRIL 8, 2020

Thanks to the unmatched generosity of the American people and the efforts of the U.S. Government, the United States has continued to lead the world’s public health and humanitarian response to the COVID-19 pandemic. We are building on that leadership, with another $225 million in health, humanitarian, and economic assistance to further boost response efforts worldwide.

This new assistance follows the nearly $274 million in aid already deployed by the U.S. government against COVID-19. It also builds upon the more than $140 billion in total U.S. health assistance alone provided globally over the last 20 years. The United States is the undisputed leader in the provision of health and humanitarian aid, around the world.

Our COVID-19 aid is focused on helping to reduce transmission of the virus through diagnosis, the prevention and control of infections in health facilities, preparing and bolstering emergency health systems, improving laboratories, training healthcare workers and more – all in an effort to respond to additional outbreaks to mitigate further impact to Americans overseas and better protect Americans at home from further transmission across our borders.

Pandemics do not respect national borders. Through decades of U.S. global leadership in health and humanitarian assistance, we know that smart and strategic investments have proven critical to protecting the homeland. As history proves, we can fight pandemics at home and help other nations contain their spread abroad.

Most importantly of all, the United States is able to provide impactful assistance to our partners overseas without diverting critical supplies away from the American people. We will keep all critical medical items in the United States until the demand at home is met.

Teams across the U.S. government — including not only the Department of State, but also the United States Agency for International Development (USAID), the Department of Health and Human Services’ Centers for Disease Control and Prevention, the U.S. Development Finance Corporation, and more — are working together and with our partners in the G7 and other multilateral institutions to prioritize programs and countries where assistance is most needed, and will have the greatest impact.

Americans don’t just provide aid through government means. Together, Americans have generously donated more than $1.5 billion to populations affected by the COVID-19 pandemic around the world through private businesses, nonprofit groups, and faith-based organizations.  And I know we will continue to do so in the weeks and months ahead, as the world’s greatest humanitarians.

Continuing U.S. Leadership in the Global COVID-19 Response Through Additional U.S. Foreign Assist...

The U.S. continues to lead the world’s public health and humanitarian response to the COVID-19 pandemic with another $225 million in foreign assistance to further boost response efforts worldwide.

state.gov

Continuing U.S. Leadership in the Global COVID-19 Response Through Additional U.S. Foreign Assist...

The U.S. continues to lead the world’s public health and humanitarian response to the COVID-19 pandemic with another $225 million in foreign assistance to further boost response efforts worldwide.

state.gov

UPDATE: The United States is Continuing to Lead the Humanitarian and Health Assistance Response to COVID-19
FACT SHEET

OFFICE OF THE SPOKESPERSON

APRIL 16, 2020

Share
The U.S. Government is leading the world’s humanitarian and health response to the COVID-19 pandemic even while we battle the virus at home. As part of this comprehensive and generous response from the American people, the U.S. Department of State and the U.S. Agency for International Development (USAID) have now committed nearly $508 million in emergency health, humanitarian, and economic assistance on top of the funding we already provide to multilateral and non-governmental organizations (NGOs) that are helping communities around the world deal with the pandemic. This funding will support critical activities to control the spread of this disease, such as rapid public-health information campaigns, water and sanitation, and preventing and controlling infections in health-care facilities.

Total U.S. government assistance in the global fight against COVID-19 provided to date includes nearly $200 million in emergency health assistance from USAID’s Global Health Emergency Reserve Fund for Contagious Infectious-Disease Outbreaks and Global Health Programs account, nearly $195 million in humanitarian assistance from USAID’s International Disaster Assistance (IDA) account, and $50 million from the Economic Support Funding (ESF), which will help governments and NGOs in more than 100 of the most affected and at-risk countries during this global pandemic. In addition, through the State Department’s Bureau of Population, Refugees, and Migration, which is responsible for the Migration and Refugee Assistance (MRA) account, we now have a country-by-country breakout of the previously announced $64 million in humanitarian assistance for the United Nations Refugee Agency (UNHCR) to address threats posed by the pandemic in existing humanitarian crisis situations for some of the world’s most vulnerable people as part of the UN’s Global Humanitarian Response Plan for COVID-19.

U.S. government departments and agencies are working together to prioritize foreign assistance based on in-country coordination and the potential for impact. With new and previously announced funds, the United States is providing the following specific assistance:

Africa:

Angola: $570,000 in health assistance is helping provide risk-communications and water and sanitation, and prevent and control infections in key health facilities in Angola. This assistance comes on top of long-term U.S. investments in Angola, which total $1.48 billion over the past 20 years, including $613 million in health assistance.
Botswana: $1.5 million in health assistance to address the outbreak. This new assistance builds on nearly $1.2 billion in total assistance in Botswana over the last 20 years, $1.1 billion of which was for health.
Burkina Faso: More than $6 million in health and humanitarian funding will go toward risk-communications, water and sanitation, preventing and controlling infections in health facilities, public-health messaging, and more. This includes $2.5 million in health assistance, $1.5 million in IDA humanitarian assistance, and more than $2.1 million in MRA humanitarian assistance, which will help protect the health of refugees, internally displaced persons, and their host communities in Burkina Faso during the pandemic. Over the past 20 years, the United States has invested more than more than $2.4 billion total in Burkina Faso, $222 million in health alone.
Cameroon: Nearly $8 million in health and humanitarian assistance will help provide infection-control in key health facilities, strengthen laboratories and surveillance, prepare communities, and bolster local messaging. This includes $6.1 million in health and IDA humanitarian assistance from USAID, in addition to nearly $1.9 million in MRA humanitarian assistance to support refugees, internally displaced persons (IDPs), and their host communities. This assistance builds upon more than $960 million in total U.S. investment in the country over the past 20 years, $390 million of which was in health.
Central African Republic: $5.2 million in humanitarian assistance, including $3.5 million in IDA humanitarian assistance that will go toward risk-communications, preventing and controlling infections in health facilities, and safe water supply, and $1.7 million in MRA humanitarian assistance that will help protect the health of refugees, internally displaced persons, and their host communities in the Central African Republic during the pandemic. The U.S. Government has provided $822.6 million in total in the Central African Republic over the last 20 years, including $4.5 million in emergency health assistance in Fiscal Year (FY) 2019.
Republic of Congo (ROC): $250,000 in health assistance will address the outbreak. The United States has invested in the Republic of Congo for decades, with more than $171.2 million in total U.S. assistance for the ROC over the last 20 years, $36.8 million of which was for health assistance.
Chad: More than $3 million in humanitarian assistance, including $1 million in IDA for preventing and controlling infections in health facilities, raising community awareness of COVID-19, and improving hygiene, and more than $2 million in MRA humanitarian assistance to help protect the health of refugees and their host communities in Chad during the pandemic. This new assistance builds upon the foundation of nearly $2 billion in total U.S. assistance over the last 20 years, including more than $30 million in health assistance.
Côte d’Ivoire: $1.6 million in health assistance to address the outbreak. Over the past 20 years, the United States has invested more than $2.1 billion in long-term development and other assistance in Côte d’Ivoire.
Democratic Republic of the Congo: $14.4 million, including $14.0 million in health assistance and IDA humanitarian assistance that will improve the prevention and control of infections in health facilities, and support improved awareness of COVID-19, including by working with religious leaders and journalists on risk-communication messaging. An additional $400,000 in MRA humanitarian assistance will help protect the health of refugees, internally displaced persons, and their host communities in the Democratic Republic of the Congo during the pandemic. This builds upon more than $6.3 billion in total U.S. assistance over the past 20 years, including nearly $37 million in health.
Djibouti: $500,000 in health assistance to address the outbreak. The United States has already invested more than $338 million total in Djibouti over the last 20 years.
Eswatini: $750,000 in health assistance to address the outbreak. Funds will go to bolstering Eswatini’s emergency health response, which may include commodity procurement, contact tracing, laboratory diagnostics, and raising public awareness. This assistance builds upon the foundation of U.S. assistance in Eswatini, which totals more than $529 million in total assistance over the last 20 years, including more than $490 million in health assistance.
Ethiopia: More than $9 million in assistance to counter COVID-19, including $8.3 million in health and IDA humanitarian assistance for risk-communications, the prevention and control of infections in health facilities, disease-surveillance, contact-tracing, and coordination; and $789,000 in MRA humanitarian assistance for refugees, internally displaced persons (IDPs), and their host communities. This assistance is in addition to the United States’ long-term investments in Ethiopia of more than $13 billion in total assistance, nearly $4 billion in health alone, over the past 20 years.
Ghana: $1.6 million in health assistance to address the outbreak. This new assistance builds upon $3.8 billion in total U.S. assistance to Ghana over the last 20 years, including nearly $914 million in health assistance.
Guinea: $500,000 in health assistance to address the outbreak. The United States has invested nearly $1 billion in total assistance for Guinea over the last 20 years, including $365.5 million in health assistance.
Kenya: Nearly $4.5 million in health and humanitarian assistance, including $3.5 million in health assistance to bolster risk communication, prepare health-communication networks and media for a possible case, and help provide public health messaging for media, health workers, and communities; and $947,000 in MRA humanitarian assistance for refugees and host communities. This COVID-19 specific assistance comes on top of long-term U.S. investment in Kenya, which totals $3.8 billion in total U.S. assistance to Kenya over the last 20 years, including $6.7 billion in health assistance alone.
Lesotho: $750,000 in health assistance to address the outbreak. This new assistance builds upon decades of U.S. investments in Lesotho, which totals more than $1 billion in total assistance over the last 20 years, including more than $834 million in health assistance.
Liberia: $1 million in health assistance will provide critical aid for all 15 Liberian counties (emergency operation centers, training, contact tracing, hospitals, and community health services), support quarantine efforts, and provide community level support. The United States has helped lay a strong foundation for Liberia’s COVID-19 response through more than $4 billion in total assistance over the past 20 years, including more than $675 million in health assistance.
Madagascar: $2.5 million in health assistance to address the outbreak. The United States has invested more than $1.5 billion in total assistance for Madagascar over the last 20 years, including nearly $722 million in health assistance alone.
Malawi: $4.5 million in health assistance to address the outbreak. The United States has provided more than $3.6 billion in total assistance for Malawi over the past 20 years, including more than $1.7 billion in health assistance.
Mali: $5.7 million in assistance for COVID-19 response includes $4.4 million in health and IDA humanitarian assistance for risk communication, infection prevention and control, and coordination, and nearly $1.3 million in MRA humanitarian assistance to support refugees, internally displaced persons, and their host communities in Mali during the pandemic. This new assistance builds upon decades of U.S. investments in Mali, which totals more than $3.2 billion in total assistance over the last 20 years, including more than $807 million in health assistance.
Mauritania: $250,000 in health assistance to address the outbreak. The United States has provided more than $424 million in total assistance over the last 20 years for Mauritania, including more than $27 million in health, building a strong foundation for their pandemic response.
Mauritius: $500,000 in health assistance to address the outbreak. This new assistance builds upon the foundation of more than $13 million in total U.S. assistance over the past 20 years, including $838,000 in health assistance.
Mozambique: $5.8 million in health and IDA humanitarian funding will help provide risk communication, water and sanitation, and infection prevention and control in key health facilities in Mozambique. The United States has invested nearly $6 billion total investment over the past 20 years, including development and other assistance, including more than $3.8 billion in health assistance.
Namibia: $750,000 in health assistance to address the outbreak. This new assistance comes in addition to nearly $1.5 billion in total U.S. assistance to Namibia over the past 20 years, including more than $970.5 million in long-term health assistance.
Niger: Nearly $4 million in assistance includes nearly $2.8 million in health and IDA humanitarian assistance for risk communication, infection prevention and control, and coordination, and $1.2 million in MRA humanitarian assistance will support refugees and their host communities in Niger during the pandemic. This assistance comes on top of more than $2 billion in total U.S. assistance for Niger in the past 20 years, nearly $233 million in health assistance alone.
Nigeria: Approximately $21.4 million in assistance includes nearly $20 million in health and IDA humanitarian funding for risk communication, water and sanitation activities, infection prevention, and coordination, and more than $1.4 million in MRA humanitarian assistance for refugees, internally displaced persons (IDPs), and their host communities. This assistance joins more than $8.1 billion in total assistance for Nigeria over the past 20 years, including more than $5.2 billion in U.S. health assistance.
Rwanda: More than $2 million in assistance for Rwanda’s COVID-19 response includes $1.7 million in health assistance that will help with surveillance and case management efforts in response to COVID-19, and $474,000 in MRA humanitarian assistance to support UNHCR’s COVID-19 response for refugees and host communities in Rwanda. This comes on top of long-term U.S. investment in Rwanda totaling more than $2.6 billion in total assistance over the past 20 years, including more than $1.5 billion in health.
Senegal: $3.9 million in health assistance to support risk communication, water and sanitation, infection prevention and control, public health messaging, and more. In Senegal, the U.S. has invested nearly $2.8 billion in total assistance over the past 20 years, nearly $880 million in health alone.
Sierra Leone: $400,000 in health assistance to address the outbreak. This assistance joins decades of U.S. investments in Sierra Leone, totaling more than $5.2 billion in total assistance over the past 20 years, including nearly $260 million in health assistance.
Somalia: Nearly $12.5 million in assistance for COVID-19 response includes $11.6 million in IDA humanitarian assistance to support risk communication, infection prevention and control, and case management, and more, as well as $892,000 in MRA humanitarian assistance to support UNHCR’s COVID-19 response in Somalia. This assistance comes in addition to $5.3 billion in total assistance for Somalia over the last 20 years, including nearly $30 million in health alone.
South Africa: Approximately $8.4 million in health assistance to counter COVID-19 will support risk communication, water and sanitation, infection prevention and control, public health messaging, and more. This assistance joins more than $8 billion in total assistance by the United States for South Africa in the past 20 years, nearly $6 billion invested in health alone.
South Sudan: $13.1 million in assistance for South Sudan’s COVID-19 response includes $11.5 million in IDA humanitarian assistance for case management, infection prevention and control, logistics, coordination efforts, risk communication, and water, sanitation and hygiene programs, and nearly $1.6 million in MRA humanitarian assistance will support refugees, internally displaced persons, and their host communities in South Sudan during the pandemic. This funding builds upon past U.S. investments in South Sudan totaling $6.4 billion for South Sudan over the past 20 years, including more than $405 million in health.
Sudan: Nearly $13.7 million in assistance includes $13 million in IDA humanitarian assistance for risk communication, case management, disease surveillance, infection prevention and control, and water, sanitation and hygiene programs, and $671,000 in MRA humanitarian assistance to support refugees, internally displaced persons (IDPs), and their host communities. The United States has invested more than $3 million in health and more than $1.6 billion in total assistance for Sudan over the last 20 years.
Tanzania: $1.4 million in health assistance supports risk communication, water and sanitation, infection prevention and control, public health messaging, and more. The United States has invested more than $7.5 billion total for Tanzania over the past 20 years, nearly $4.9 billion in health alone.
Uganda: $3.6 million in assistance includes $2.3 million in health assistance to address the outbreak and nearly $1.3 million in MRA humanitarian assistance will support refugees and their host communities in Uganda during the pandemic. This assistance is provided in addition to the nearly $8 billion in total U.S. assistance for Uganda over the last 20 years and $4.7 billion in health assistance alone.
Zambia: $3.4 million in health assistance supports risk communication, water and sanitation, infection prevention and control, public health messaging, and more. This new assistance joins $4.9 billion total U.S. assistance for Zambia over the past 20 years, nearly $3.9 billion in U.S. health assistance alone.
Zimbabwe: Nearly $3 million in health and IDA humanitarian assistance will help to prepare laboratories for large-scale testing, support case-finding activities for influenza-like illnesses, implement a public-health emergency plan for points of entry, and more. This new assistance builds on a history of U.S. investments in Zimbabwe – nearly $3 billion total over the past 20 years, nearly $1.2 billion in health assistance.
Europe and Eurasia:

Albania: $1.2 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. Over the last 20 years, the United States has invested more than $693 million in total assistance to Albania, including more than $51.8 million in health assistance.
Armenia: $1.7 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. The United States has invested more than $1.57 billion in total assistance to Armenia over the past 20 years, including nearly $106 million in health assistance.
Azerbaijan: $1.7 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. Over the past 20 years, the United States has invested more than $894 million in total assistance to Azerbaijan, including nearly $41 million in health assistance.
Belarus: $1.3 million in health funding is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This new assistance comes on top of decades of U.S. investment in Belarus, totaling more than $301 million in total U.S. assistance over the past 20 years, including nearly $1.5 million in health assistance.
Bosnia and Herzegovina: $1.2 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. The United States has invested more than $1.1 billion in total assistance for Bosnia and Herzegovina over the past 20 years, including $200,000 in health assistance.
Bulgaria: $500,000 in health assistance to address the outbreak. This new assistance builds on longstanding U.S. assistance for Bulgaria, which totals more than $558 million in total assistance over the past 20 years, including more than $6 million in health assistance.
Georgia: $1.7 million in health funding is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. The United States has provided more than $3.6 billion in total U.S. assistance over the past 20 years, including nearly $139 million in health assistance.
Greece: $500,000 in MRA humanitarian assistance will support COVID-19 response efforts for migrants and refugees in Greece. This new assistance builds upon a foundation of U.S. support for Greece, which totals more than $202 million in total U.S. assistance over the last 20 years, including nearly $1.8 million in health assistance.
Italy:S. support will include $50 million in economic assistance implemented by USAID to bolster Italy’s COVID-19 response. USAID will expand and supplement the work of public international organizations, non-governmental organizations, and faith-based groups responding to the pandemic in Italy and mitigating its social and community impact. USAID will also purchase health commodities that are not required for the U.S. domestic response; and work to support Italian companies engaged in developing and producing medical equipment and supplies for COVID-19.
Kosovo: $1.1 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This assistance to combat COVID-19 is in addition to long-term U.S. investments which total over $772 million in total assistance in Kosovo over the past 20 years, including more than $10 million in health assistance.
Moldova: $1.2 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This COVID-19 assistance builds upon U.S. investments of more than $1 billion in total assistance, which includes nearly $42 million in health assistance over the past 20 years.
Montenegro: $300,000 in health assistance to address the outbreak. This new assistance joins long-term U.S. investment in Montenegro totaling more than $332 million, including more than $1 million for health assistance.
North Macedonia: $1.1 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. Over the past 20 years, the United States has invested more than $738 million in total assistance for North Macedonia, including nearly $11.5 million in health assistance.
Romania: $800,000 in health assistance to address the outbreak. In addition, the U.S. Government fully funded a NATO operation to transport PPE from South Korea to Romania, and U.S. military personnel were members of air crews manning two other flights delivering PPE to Romania using the NATO-supported Strategic Airlift Capability. The United States has invested in Romania for decades, totaling nearly $700 million in total U.S. assistance in the last 20 years, including more than $55 million in health assistance.
Serbia: $1.2 million in health assistance is helping: expand testing, activate case-finding and event-based surveillance; deploy additional technical expertise for response and preparedness; bolster risk communication and community engagement; and improve hygiene practices in the home. In addition, USAID/Serbia has also redirected $150,000 to provide food and other essential support to Serbia’s most vulnerable families and groups, including the elderly. The United States has invested more than $1 billion in total assistance to Serbia over the past 20 years, including nearly $5.4 million in health assistance.
Turkey: $800,000 in MRA humanitarian assistance will support COVID-19 response efforts for refugees and their host communities in Turkey. This new funding is in addition to the $18 million for Syrian refugee assistance inside Turkey announced March 3, and builds upon nearly $1.4 billion in total U.S. assistance to Turkey over the past 20 years, including more than $3 million in health assistance, helping lay the foundation for the current response.
Ukraine: $9.1 million in health and IDA humanitarian assistance will help prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. Assistance will also prevent and control infection at targeted health facilities; and support water, sanitation and hygiene interventions for the most vulnerable populations in Donetsk and Luhansk. The United States has invested nearly $5 billion in total assistance to Ukraine over the past 20 years, including nearly $362 million in health assistance.
Asia:

Afghanistan: More than $18 million in total U.S. assistance for Afghanistan’s COVID-19 response includes more than $5.6 million in health and IDA humanitarian assistance to support detection and treatment of COVID-19 for internally displaced persons (IDPs), and nearly $2.4 million in MRA humanitarian assistance for Afghan returnees. This also includes $10 million in existing resources the United States Has redirected to support the United Nations Emergency Response Plan for COVID-19. This support will include surveillance, lab improvements, case management, infection prevention and control, community engagement, and technical assistance to the Government of Afghanistan.
Bangladesh: Nearly $9.6 million in assistance includes $4.4 million in health and IDA humanitarian assistance to help with case management, surveillance activities, infection prevention and control, risk communication, and water, sanitation, and hygiene programs, and $5.2 million in MRA humanitarian assistance to support refugees and their host communities in Bangladesh during the pandemic. This builds upon nearly $4 billion in total U.S. assistance over the past 20 years, which includes more than $1 billion in health assistance alone.
Bhutan: $500,000 in health assistance will strengthen diagnostic laboratory capabilities and clinical case management, provide virtual training for health care providers and lab personnel, and support risk communications materials. This assistance builds upon more than $6.5 million in total U.S. assistance over the past 20 years, including $847,000 in health assistance.
Burma: Approximately $4.1 million in health and $3 million in IDA humanitarian funding goes toward COVID-19 infection prevention and control, case management, laboratory system strengthening, risk communications and community engagement, as well as water and sanitation supplies, including assistance to IDP camps that are facing shortages. This assistance comes on top of long-term U.S. investment in Burma including more than $1.3 billion in total U.S. assistance, which includes more than $176 million in health assistance, over the past 20 years.
Cambodia: Approximately $4 million in health assistance is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, communicate risk, support technical experts for response and preparedness, and more. The United States has invested long-term in Cambodia, providing more than $1.6 billion in total assistance, which includes more than $730 million in health assistance, over the past 20 years.
India: Nearly $5.9 million in health assistance to help India slow the spread of COVID-19, provide care for the affected, disseminate essential public health messages to communities, strengthen case finding and surveillance, and mobilize innovative financing mechanisms for emergency preparedness and response to this pandemic. This builds on a foundation of nearly $2.8 billion in total assistance, which includes more than $1.4 billion in health assistance, the United States has provided to India over the last 20 years.
Indonesia: Nearly $5 million includes more than $4.5 million in health assistance to help the government prepare laboratory systems, activate case-finding and event-based surveillance, and support technical experts for response and preparedness, and more. It also includes $400,000 in MRA humanitarian assistance. The United States has invested more than $5 billion in total assistance over the past 20 years, including more than $1 billion in health assistance.
Kazakhstan: More than $1.6 million in health assistance will help prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This new assistance builds upon U.S. investments of more than more than $2 billion in total assistance over the last 20 years, including $86 million in health assistance.
Kyrgyzstan: Approximately $900,000 in health assistance will help prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. The United States has invested nearly $1.2 billion in total assistance for Kyrgyzstan over the past 20 years, including more than $120 million in health assistance.
Laos: Nearly $3.5 million in health assistance is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, and more. This assistance builds upon U.S. investment in Laos over time, including more than $348 million total over the past decade, of which nearly $92 million was health assistance.
Malaysia: $200,000 in MRA humanitarian assistance will support COVID-19 response efforts for refugees and asylum seekers in Malaysia. This assistance builds upon a foundation of decades of U.S. investment in Malaysia, totaling more than $288 million in total assistance over the past 20 years, including more than $3.6 million in health assistance.
Mongolia: Nearly $1.2 million in health assistance is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, and support technical experts for response and preparedness, and more. The United States has invested more than $1 billion in total assistance for Mongolia over the past 20 years, including nearly $106 million in health.
Nepal: $1.8 million in health assistance is helping the government to conduct community-level risk communications, prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, and more. Over the past 20 years, U.S. investment in Nepal totals more than $2 billion, including more than $603 million in health alone.
Pacific Islands: $3.3 million total includes $2.3 million in health assistance which is helping governments prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, and $1 million in IDA humanitarian assistance to support risk communication, infection prevention and control, logistics, coordination efforts, and more. Over the last 20 years, the United States has invested over $5.21 billion in assistance to the Pacific Islands. Over the last decade, the United States has invested more than $620 million in health assistance alone for the Pacific Islands.
Papua New Guinea: $1.2 million in health assistance for Papua New Guinea is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, and support technical experts for response and preparedness, risk communication, infection prevention and control, and more. The United States has invested over $108 million total in Papua New Guinea over the past 20 years, including more than $52 million in health alone.
Pakistan: $9.4 million in new funding for Pakistan’s COVID-19 response includes $7 million in health assistance to help Pakistan strengthen monitoring and better prepare communities to identify potential outbreaks. In addition, $2.4 million in MRA humanitarian assistance will support COVID-19 response efforts for refugees in Pakistan. To bolster its national COVID-19 action plan, the United States has also redirected more than $1 million in existing funding for training of healthcare providers and other urgent needs. S. long-term investment in Pakistan over the past 20 years includes more than $18.4 billion in total assistance, which includes $1.1 billion in health alone.
Philippines: More than $6 million in health and $2.8 million in IDA humanitarian assistance will help support laboratory and specimen-transport systems, intensify case-finding and event-based surveillance, support Philippine and international technical experts for response and preparedness, risk communication, infection prevention and control, handwashing and hygiene promotion, community-level preparedness and response, and more. The United States has invested more than $4.5 billion in total assistance over the past 20 years, which includes $582 million in the Philippines’ health alone.
Sri Lanka: $1.3 million in health assistance is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, risk communication, infection prevention and control, and more. Over the past 20 years, U.S. investment in Sri Lanka has included more than $1 billion in total assistance, which includes $26 million in health alone.
Tajikistan: Approximately $866,000 in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This assistance builds on U.S. investments of more than $1 billion in total assistance over the past 20 years, which includes nearly $125 million in health
Thailand: More than $2.7 million in health assistance will help the government prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, risk communication, infection prevention and control, and more. This new assistance builds upon long-term U.S. assistance in Thailand including more than $1 billion in total assistance over the past 20 years, which includes nearly $213 million in health
Turkmenistan: Approximately $920,000 in health assistance has been made available to help prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. Over the past 20 years, the United States has collaborated closely with the Government of Turkmenistan and local partners to implement bilateral and regional programs totaling more than $201 million, including over $21 million in health assistance, over the past 20 years.
Timor-Leste: $1.1 million in health assistance is helping the government prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, risk communication, infection prevention and control, and more. The United States has invested more than $542 million in total assistance for Timor-Leste since independence in 2002, including nearly $70 million in health assistance.
Uzbekistan: Approximately $848,000 in health funding is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This COVID-19 response assistance builds upon long-term U.S. investment of more than $1 billion in total assistance over the past 20 years, including more than $122 million in health assistance.
Vietnam: Nearly $4.5 million in health assistance to help the government prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for preparedness and response, risk communication, infection prevention and control, and more. Over the past 20 years, the United States has invested more than $1.8 billion in total assistance for Vietnam, including more than $706 million in health assistance.
Regional Efforts in Asia: $800,000 in health assistance is helping governments across the region prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, risk communication, infection prevention and control, and more. The United States has provided more than $226 million in health assistance regionally in addition to health assistance to individual countries in the region, and in total more than $3 billion in development and other assistance over the last 20 years.
Latin America and the Caribbean:

Belize: $300,000 in health assistance to address the outbreak and improve operational capacity and case management. This new assistance builds upon past U.S. investment in Belize, which totals more than $120 million over the past 20 years, including nearly $12 million in health assistance.
Bolivia: $750,000 in health assistance to build capacity in COVID-19 diagnostics and improve epidemiological surveillance. This new assistance joins long-term U.S. investment in Bolivia, including nearly $2 billion in total U.S. assistance over the past 20 years, which includes $200 million in health assistance.
The Eastern and Southern Caribbean: $1.7 million in previously announced funding is helping 10 countries in the Eastern and Southern Caribbean scale up their risk communication efforts, water and sanitation, prevent and control infections, manage COVID-19 cases, strengthen laboratories, and surveil the spread of the virus. This builds upon decades of strategic U.S. investment in the region, including more than $840 million total over the past 20 years, which includes $236 million in health.
Colombia: More than $10.4 million in humanitarian assistance for Colombia’s COVID-19 response includes $8.5 million in previously announced IDA humanitarian assistance that is helping surveil the spread of the virus, provide water and sanitation supplies, manage COVID-19 cases, and more; and $1.9 million in MRA humanitarian assistance, which will support efforts to help refugees and their host communities in Colombia during the pandemic. Additionally, the United States has already redirected $6 million to address COVID-19-related impacts on the public health system, support mayors and communities to prevent the spread of the virus, and offer legal and psychosocial support to victims of domestic violence. In Colombia, the United States has invested nearly $12 billion in total assistance over the past 20 years, which includes approximately $32.5 million in health assistance.
Dominican Republic: $1.4 million in previously announced health assistance to address the outbreak. The funding will support epidemiological analysis and forecasting, identification and follow-up of contact tracing, as well as pandemic surveillance. The United States has invested in the Dominican Republic’s long-term health and development through more than $1 billion in total U.S. assistance over the past 20 years, which includes nearly $298 million in health assistance.
El Salvador: Nearly $2.6 million in new health assistance for El Salvador is helping to address the outbreak. Support will include infection prevention, control, and case management. Over the past 20 years, the United States has invested in El Salvador’s health and long-term development through more than $2.6 billion in total assistance, which includes $111 million in health assistance.
Ecuador: $2 million in new health assistance will provide technical support and training in diagnostics, and technical assistance in clinical management. The United States’ long-term commitment to Ecuador includes more than $1 billion in total assistance, which includes nearly $36 million in health assistance over the last 20 years – helping Ecuador respond to major public health challenges such as Zika and Malaria.
Guatemala: More than $2.4 million in health assistance for Guatemala will help address the outbreak. S. long-term investment in Guatemala’s health and development includes more than $2.6 billion in total U.S. assistance, which includes $564 million in health, over the past 20 years.
Haiti: $13.2 million in health and IDA humanitarian assistance for Haiti will support risk communication efforts, improved water and sanitation, infection prevention, COVID-19 case management, laboratories, and more. The United States has invested nearly $6.7 billion in total assistance, including more than $1.8 billion in health in Haiti over the past 20 years.
Honduras: More than $2.4 million in health assistance for Honduras will help address the outbreak. In addition, the United States has also redirected $1.8 million in existing resources to support the operation of migrant reception centers and adapt existing programs to respond to COVID-19. The United States has also invested nearly $1.9 billion in total assistance, which includes $178 million in health assistance, for Honduras over the past 20 years.
Jamaica: $700,000 in previously announced health funding is supporting risk communication efforts, water and sanitation, COVID-19 prevention, control, and management, and virus surveillance. This assistance builds upon U.S. investments of nearly $619 million total over the past 20 years, including nearly $87 million in health assistance.
Mexico: $500,000 in MRA humanitarian assistance will support COVID-19 response efforts to help refugees in Mexico. U.S. long-term investment in Mexico has helped build the foundation for their COVID-19 response – this adds up to nearly $4.8 billion in total U.S. assistance over the past 20 years, including more than $61 million in health assistance.
Panama: $750,000 in health assistance will help address the outbreak for a strategic U.S. partner. Assistance will optimize country health system capacity to care for COVID-19 patients, protecting the most vulnerable. The United States has a history of investing in Panama’s health and long-term development with more than $425 million in total U.S. assistance over the past 20 years, including more than $33.5 million in health assistance.
Paraguay: $1.3 million in new health assistance will support risk communication efforts, prevent and control infections, manage COVID-19 cases, strengthen laboratories, and surveil the spread of the virus. S. investment in Paraguay is long-term and totals more than $456 million total over the past 20 years, including more than $42 million in health assistance.
Peru: $2.5 million in health assistance to provide technical assistance and training in surveillance, infection prevention and control, risk communication, and community engagement. The United States’ strong history of investing in Peru’s health and long-term development has laid the foundation for Peru’s response, with more than $3.5 billion in total U.S. assistance over the last 20 years, including nearly $265 million in health assistance.
Venezuela: $9 million in IDA humanitarian assistance to the Venezuelan people is helping surveil the spread of the virus, provide water and sanitation supplies, manage COVID-19 cases, and more. In Venezuela, the U.S. has invested more than $278 million in total long-term assistance over the past 20 years, including more than $1.3 million in direct health assistance. In the last year, the U.S. provided additional lifesaving humanitarian assistance and development programming inside Venezuela that are not yet captured in these amounts.
Regional Efforts in Latin America and the Caribbean: Additionally, $500,000 in MRA humanitarian assistance will support regional efforts to help Venezuelans in the region during the pandemic. In addition, the United States has also redirected $6.2 million in existing resources to support regional COVID-19 response in El Salvador, Guatemala, and Honduras.
Middle East and North Africa:

Algeria: $500,000 to support Algeria’s response to COVID-19 and mitigate its impact on Algerian society by strengthening risk communication and community engagement approaches under the GoA preparedness and response plan.
Iraq: More than $25.6 million in COVID-19 assistance for Iraq includes more than $19.1 million in health and IDA humanitarian assistance that is helping prepare laboratories, implement a public-health emergency plan for points of entry, activate case-finding and event-based surveillance for influenza-like illnesses, and more. The funding includes $6.5 million in MRA humanitarian assistance to assist internally displaced Iraqis, refugees living in Iraq, and their host communities. This new assistance builds upon long-term investment in Iraq, which adds up to more than $70 billion in total U.S. assistance in the past 20 years, including nearly $4 billion in the health sector alone.
Jordan: $8 million in assistance includes $6.5 million in MRA humanitarian assistance to support COVID-19 response efforts to help refugees in Jordan, and $1.5 million in health assistance, which will support infection prevention and control to stop the spread of the disease, as well as laboratory strengthening for large-scale testing of COVID-19. The United States also is spearheading donor support to the Government of Jordan, coordinating life-saving assistance and prioritizing investments to respond rapidly now and to plan ahead as the threat evolves. Our investments in the last 20 years alone total more than $18.9 billion in total assistance, including more than $1.8 billion in health assistance.
Lebanon: $13.3 million in new assistance for Lebanon includes $5.3 million in IDA humanitarian assistance for COVID-19 response activities targeting vulnerable Lebanese, such as supporting private health facilities to properly triage, manage, and refer patients; ensure continuity of essential health services; carry out risk communication and community outreach activities, and increase access to water, sanitation, and hygiene. $8 million in MRA humanitarian assistance will support COVID-19 response efforts to help refugees and their host communities in Lebanon. This assistance builds upon the nearly $4.9 billion in bilateral assistance, including more than $187 million in health assistance, that the U.S. has provided for Lebanon in the last 20 years. In addition to the bilateral funding, the U.S. has provided more than $2.3 billion in humanitarian assistance to respond to the Syria crisis in Lebanon.
Libya: $6 million in IDA humanitarian assistance is being provided for Libya to support risk communication, improve case management, bolster coordination for an effective COVID-19 response, and strengthen infection prevention and control.
Morocco: Nearly $1.7 million in health assistance is helping prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. This assistance builds upon long-term U.S. investments in Morocco adding up to more than $2.6 billion in total assistance over the last 20 years, including $64.5 million in health assistance.
Syria: Nearly $18 million for the COVID-19 response in Syria includes $16.8 million in IDA humanitarian assistance to support risk communication, disease surveillance, water, sanitation and hygiene programs, infection prevention and control. There is nearly $1.1 million in additional MRA humanitarian assistance. This assistance joins decades of U.S. investments for the Syrian people, including more than $10 billion in humanitarian assistance for people in need inside Syria, Syrian refugees, and their host communities since the beginning of the conflict. Humanitarian assistance, including medicines and medical supplies, is exempt from any current sanctions across all areas of Syria.
Tunisia: $600,000 in health assistance will help prepare laboratory systems, activate case-finding and event-based surveillance, support technical experts for response and preparedness, bolster risk communication, and more. The United States has invested more than $1.3 billion in total U.S. assistance for Tunisia over the past 20 years, including more than $7 million in health assistance.
West Bank/Gaza: Approximately $5 million in International Disaster Assistance is helping provide immediate, life-saving assistance in the West Bank.
Yemen: $500,000 in MRA humanitarian assistance will support COVID-19 response efforts to help refugees and other vulnerable populations in Yemen. In the past 20 years, the United States has provided nearly $4 billion in total assistance for Yemen’s long-term development, including nearly $132 million in health assistance.
Global:

Approximately $35.5 million in global and regional programming is being provided through international organizations and NGOs, including for programs that support supply-chain management, new partnerships, monitoring and evaluation, and more.
$8 million in MRA humanitarian assistance for UNHCR’s global COVID-19 response to address the challenges posed by the pandemic in refugee, IDP, and hosting communities.
In addition to this direct U.S. government funding, our All-of-America approach is helping people around the world through the generosity of private businesses, nonprofit groups, charitable organizations, faith-based organizations, and individuals. Together, Americans have provided nearly $3 billion in donations and assistance, in addition to what the U.S. Government has provided.

U.S. investments under the Global Health Security Agenda, including those we have contributed to this global crisis response, are designed to protect the American public by helping to minimize the spread of disease in affected countries and improve local and global responses to outbreaks of infectious pathogens.

Ongoing U.S. COVID-19 assistance builds on the United States’ record of leadership in global health and humanitarian assistance. This assistance is part of a larger USG global response package across multiple departments and agencies, including the Centers for Disease Control and Prevention (CDC). Since 2009, American taxpayers have generously funded more than $100 billion in health assistance and nearly $70 billion in humanitarian assistance globally. Our country continues to be the single largest health and humanitarian donor for both long-term development and capacity building efforts with partners, and emergency response efforts in the face of recurrent crises. These resources have saved lives, protected people who are most vulnerable to disease, built health institutions, and promoted the stability of communities and nations.

For more information on the U.S. government’s holistic funding in response to this crisis, please contact F-Press@state.gov.

For details on specific in-country response activities, please contact USAID at press@usaid.gov.

For details on the humanitarian assistance contribution to UNHCR, please contact the State Department’s Bureau for Population, Refugees, and Migration at PRM-Press@state.gov.

Pekini mund ta ketë krijuar Covid-19 në laborator për të treguar supermaci…

Shpërthimi i koronavirusit ndodhi për shkak të rivalitetit mes SHBA dhe Kinës? Mediat amerikane: Pekini mund ta ketë krijuar Covid-19 në laborator për të treguar supermaci…

Një ndër mediat kryesore amerikane Fox News ka raportuar, se duke iu referuar disa burimeve afër qeverisë kineze, shpërthimi i koronavirusit në disa laboratore të Kinës mund të ketë filluar, për shkak të rivalitetit që ekziston mes SHBA-ve dhe shtetit kinez.



“Kina mund ta ketë filluar shpërthimin e koronavirusit në laboratoret e veta, që më pas të demonstrojë para botës se di ta mbyllë më shpejt një rast virusi e se shëndetësia e saj është më e mirë se e Amerikës”, kanë thënë burime anonime për këtë media amerikane.

Burime për median në fjalë kanë thënë se fillimisht virusi mund të jetë prodhuar në laborator, atë e ka marrë një person e pacienti zero ka dalë jashtë e ua ka transmetuar njerëzve në qytetin e Uahanit.


Fox News insiston që të shikohen provat për këtë gjë. I pyetur për median në fjalë, presidenti amerikan Donald Trump tha se do të hetohet rasti një më një dhe se i duket gjithcka një “skenar i tmerrshëm”.

Fajësimi i një tregu shihet si justifikim, pasi aty nuk shiten kurrë lakuriqë. Në fakt, virusi mund të ketë origjinën në një laborator. Zyrtarët e ambasadës amerikane paralajmëruan në janar të vitit 2018 për një lidhje me sigurinë e pamjaftueshme në laboratorin e Institutit të Virologjisë në Wuhan. Ata thanë se aty bëhen “kërkime të rrezikshme për Covid-19”.

Top sekrt: Zbulohet plani i SHBA/ Zyrtarët e qeverisë janë për rihapje të vendit: Fillon me shkollat dhe kishat nga 1 maji

Zyrtarët e qeverisë së SHBA kanë nënshkruar një plan që prej 1 majit  2020 të hapen të gjitha shkollat, kampet dhe kishat në vend.



Ky plan është hartuar nga Agjencia Federale e Menaxhimit të Emergjencave si dhe Qendra për Kontrollin e Sëmundjeve që japin dhe rrugën se si SHBA do të fillojë kthimin drejt normalitetit.


Plani në fakt është me 8 pika dhe prej 1 majit 2020 parashikon hapjen e këtyre institucioneve, më pas më 15 maj  2020 pritet rritja e kiteve të testimeve dhe fondeve të emergjencës.

Për pikat e tjera nuk dihet por në dokument sipas mediave të huaja flitet dhe për një nivel risku që mund të shkaktojë rihapja në luftën ndaj COVID-19.

Kur Presidenti amerikan Donald Trump e përmendi për herë të parë koronavirusin, mund të ketë qenë vonë në reagimin e duhur.

“Në prill zhduket si për mrekulli”, Zëri i Amerikës: Trump nuk i kushtoi rëndësi virusit në Kinë, kur reagoi për herë të parë mund të ishte vonë


Kur Presidenti amerikan Donald Trump e përmendi për herë të parë koronavirusin, mund të ketë qenë vonë në reagimin e duhur.



Në një intervistë gjatë takimeve të Davosit, më 22 janar 2020 , presidenti nuk i kushtoi rendësi virusit që kishte goditur Kinën, ndërkohë që një rast i vetëm ishte identifikuar në SHBA.

“E kemi plotësisht nën kontroll. Vetëm një individ që ka ardhur nga Kina, e kemi nën kontroll. Gjithçka do të shkojë mirë”.

Në 11 javët që kanë kaluar që nga ajo intervistë, koronavirusi është shfaqur në çdo cep të botës, ka infektuar mbi 550 mijë amerikanë dhe ka shkaktuar vdekjen e të paktën 22 mijë prej tyre. Si rezultat i epidemisë, janë vënë në zbatim izolime në masë, janë mbyllur shkolla e biznese, është goditur rëndë ekonomia duke lënë miliona vetë pa punë.

Kur Presidenti amerikan Donald  Trump u intervistua në Zvicër, kishte disa javë që ishin ngritur shqetësime. Në muajt në vazhdim, para se presidenti të fliste për krizën në Shtëpinë e Bardhë, nuk u shfrytëzua mundësia për të marrë masa për të mbrojtur vendin në kohë.

Nuk u krijuan rezerva me pajisje të domosdoshme mjekësore. Udhëtimet vazhduan në masë të madhe të pakufizuara. Nuk u mblodhën të dhëna nga Kina: Pekini nuk i ofronte dhe nga ana tjetër konsideroheshin të pavlefshme. Konfliktet e brendshme në Shtëpinë e Bardhë dhe ndryshimi i vazhdueshëm i zyrtarëve e bëri reagimin edhe më të ngadaltë. Paralajmërimet u injoruan nga presidenti, i cili ishte i preokupuar me komentet pas përpjekjeve për largimin e tij nga posti dhe tek synimet për të mbrojtur ekonominë, të cilën e konsideront si garancinë kryesore për rizgjedhje.

20 zyrtarë aktualë dhe të mëparshëm si dhe republikanë me lidhje të forta me Shtëpinë e Bardhë dhanë intervista për raportimin investigativ të agjencisë Associated Press, lidhur me reagimin para fjalimit të Presidentit Trump më 26 shkurt. Shumë prej tyre folën në kushte anonimiteti pasi nuk ishin të autorizuar të jepnin komente zyrtare.

“PNEUMONI MISTERIOZE”

Më 31 dhjetor 1999, Kina informoi Organizatën Botërore të Shëndetësisë për një “pneumoni misterioze” që ishte shfaqur dhe po përhapej në Wuhan, një qytet me 11 milionë banorë.

Qeveria mbylli tregun e peshkut, ku ishte shfaqur epidemia fillimisht. Pacientët u vendosën në një spital të veçantë dhe u mblodhën mostra për t’u analizuar nga laboratorët qeveritarë. Mjekët u urdhëruan të mos komentojnë. Një mjek që foli haptazi përmes internetit, u ndëshkua. Ai vdiq më pas nga COVID-19.

Pentagoni mësoi për herë të parë mbi shfaqjen e koronavirusit në dhjetor nga lajmet që vinin nga Kina. Në fillim të janarit, paralajmërimet për virusin kishin filluar të shfaqeshin në raportet e agjencive të zbulimit.

Më 3 janar, kreu i Qendrës për Kontrollin dhe Parandalimin e Sëmundjeve, Robert Redfield, mori paralajmërim zyrtar përmes një telefonate nga homologu i tij kinez.

Dr. Anthony Fauci, eksperti kryesor amerikan për sëmundjet infective, u njoftua në të njëjtën kohë për kërcënimin.

Zyrtarë të zbulimit dhe shëndetit publik filluan të shfaqin dyshim që Kina po raportonte me vertetësi numrin e të vdekurve dhe të infektuarve. Ata kërkuan nga Kina qasje për epidemiologët amerikanë, si për të ndihmuar, ashtu edhe për të analizuar nga afër situatën në mënyrë që të parandalonin problemin në SHBA. Zyrtarët amerikanë i kërkuan Kinës mostra të virusit që të studioheshin nga laboratorët amerikanë për të zhvilluar vaksina e teste.

Më 11 janar 2020  Kina dërgoi sekuencën gjenetike të virusit. Po atë ditë, Instituti Kombëtar i Shëndetit filloi punën për të identifikuar një vaksinë.

Më në fund, Shtetet e Bashkuara arritën të sigurojnë miratim nga Kina që dy specialistë amerikanë të dërgoheshin me një ekip të OBSH në kinë në fund të muajit. Por deri në atë moment, javë të tëra të vyera për të luftuar epideminë ishin humbur, ndërkohë që virusi përhapej në Azi dhe kishte filluar të mbërrinte edhe në pjesë të tjera të globit.

GJETJA E BALANCËS

Në pjesën më të madhe të janarit, zyrtarët po përpiqeshin të gjenin një balancë delikate. Në qarqe të brendshme ata po u binin këmbanave të alarmit për nevojën që specialistë amerikanë të analizonin situatën në Kinë. Nga ana tjetër, publikisht flisnin me tone optimiste duke lavdëruar Pekinin që kishte lejuar specialistët amerikanë në Kinë.

Matthew Pottinger, ndihmës këshilltar i presidentit për sigurinë kombëtare, këmbëngulte se nevojitej reagim më agresiv për të kërkuar informacion nga Kina dhe për të dërguar atje ekipe shkencëtarësh.

Megjithëse kërcënimi përfshihej në një numër raportesh për informimin e presidentit të përgatitura nga agjencitë e zbulimit, zoti Trump nuk u informua plotësisht për kërcënimin deri kur Sekretari i Shëndetit Alex Azar më 18 janar 2020 kontaktoi presidentin ndërkohë që ai ishte në rezidencën e pushimeve në Florida.

Presidenti donte të fliste për produktet e duhanit përmes vaping, pasi po analizonte një urdhëresë të re për të kufizuar përdorimin e tyre. Zyrtarët e Shtëpisë së Bardhë besojnë tani se presidenti nuk e kuptonte plotësisht se çfarë kërcënimi po afrohej, pjesërisht pasi Sekretari Azar, i cili në atë kohë kishte konflikte me një numër zyrtarësh të administratës, nuk arriti ta komunikonte qartë këtë rrezik.

Sekretari Azar po përpiqej të ruante një balancë të vështirë: të mos i kundërvihej direkt komenteve optimiste të presidentit dhe nevojës për të përgatitur qeverinë për rrezikun: “Kërcënimi ndaj Amerikës është i ulët për momentin. Por kjo mund të ndryshojë shumë shpejt,” tha zoti Azar në atë kohë në një seancë për informimin e ligjvënësve.


Presidenti ishte në atë kohë në mes të procesit në Senat për largimin e tij të mundshëm nga posti. Zoti Trump ishte plotësisht i preokupuar nga procesi gjyqësor në Senat, duke folur në çdo koment publik kundër demokratëve, apo duke u ankuar për padrejtësi në bisedat me këshilltarët larg syve të publikut.

Po ashtu, Presidenti Trump nuk donte të ushtronte presion ndaj Presidentit kinez, Xi Jinping, me të cilin po punonte për të zgjidhur konfliktet tregtare, shumë të nevojshme për mbarëvajten e ekonomisë, ndërkohë që afrojnë zgjedhjet presidenciale. Kur presidenti iu përgjigj për herë të parë një pyetjeje për koronavirusin në Davos, ai foli me lëvdata entuziaste për Presidentin Xi dhe përgjigjen e Kinës ndaj situatës, duke kapërcyer reagimin e matur që kishn përgatitur ndihmësit e tij.

KONFLIKTET E BRENDSHME

Në rrethin e brendshëm të stafit të presidentit kishte kaos dhe paqartësi.

Në fund të janarit 2020 , shefi i personelit në detyrë, Mick Mulvaney pritej t’i kishte ditët të numëruara. Ai ishte në grupin fillestar të punës kundër koronavirusit, ku mbizotëronin konfliket dhe rivalitetet. Ndërkohë, Zyra e presidentit për Menaxhimin dhe Buxhetin po konkurronte me Departamentin e Shëndetit për fonde kundër virusit.

Departamenti i Shëndetit donte t’i kërkonte Kongresit fonde speciale për të luftuar virusin, por Zyra për Buxhetin këmbëngulte se departamenti duhet të përdorte 250 milionë dollarë të buxhetit ekzistues duke i zhvendosur nga synimi fillestar dhe t’i përdorte tani për të blerë pajisje mbrojtëse për personelin mjekësor. Departamenti këmbëngulte se mund të blinte maska, aspiratorë apo veshje mbrojtëse pa autorizim nga Kongresi.

Kongresi miratoi fillimisht 8 miliardë dollarë për pajisje, një ndër tre paketat stimuluese në përgjigje të epidemisë.

Ndërkohë që vazhdonin konfliktet mes dy autoriteteve federale, askush brenda rrethit të ngushtë të presidentit nuk po e nxiste zotin Trump për veprim. Presidenti mbante rrotull vetes individë besnikë, të paktë ishin ata që mund ta bindnin presidentit të ndryshonte opinion për situatën. Në mes të janarit, në Shtëpinë e Bardhë po zhvilloheshin mbledhje që kishin në tematikë koronavirusin, por përqëndroheshin tek nevoja për të nxjerrë nga Kina punonjësit e qeverisë amerikane, pa i kushtuar rendësi kërcënimit që i kanosej vetë SHBA nga epidemia.

Më 29 janar 2020, këshilltari i Shtëpisë së Bardhë Peter Navarro parashikoi me saktësi disa nga sfidat me të cilat do të ndesheshin Shtetet e Bashkuara nëse plaste epidemia. Ai nuk ishte zyrtari i parë që theksonte rrezikun. Por ashtu si Matthew Pottinger, ndihmës këshilltar i presidentit për sigurinë kombëtare, zoti Navarro shihej në Shtëpinë e Bardhë si reagim i zyrtarëve që e shohin negativisht bashkëpunimin me Kinën. Shqetësimet e tyre u hodhën poshtë nga zyrtarë të tjerë të administratës, të cilët nuk informuan presidentin.

Më 30 janar 2020, Organizata Botërore e Shëndetësisë e shpalli virusin një kërcënim global, ndërkohë që presidenti zhvillonte tubim para një salle të mbushur me përkrahës në Ajova. Të nesërmen, administrata Trump ndaloi futjen në ShBA të shtetasve të huaj që brenda 14 ditëve të mëparshme kishin qenë në Kinë. Kufizimet preknin edhe familjarë të shtetasve amerikanë dhe të personave që kishin leje të përhershme qëndrimi në SHBA.

Presidenti e prezantoi si një reagim të guximshëm, megjithëse vazhdonte të nënvlerësonte kërcënimin në komentet e tij. Megjithë kufizimet, afro 40 mijë vetë kanë mbërritur në SHBA në avionë që niseshin direkt nga Kina që nga ajo ditë, sipas një analize të së përditshmes The New York Times.

“JEMI SHUMË, SHUMË TË PËRGATITUR”

Më 10 shkurt 2020, Presidenti  Donald Trump doli para mijëra përkrahësve në Nju Hempshër dhe deklaroi “Në prill, e dini, në teori, zhduket si për mrekulli”.

Turma brohoriti duke mbështetur deklaratën e presidentit që nuk gëzon baza shkencore. Senati kishte liruar presidentin nga akuzat dhe tani ai i kishte përqëndruar forcat tek rizgjedhja në nëntor, ndërkohë që zyrtarët e administratës kishin filluar të përqëndroheshin tek virusi.

Zyrtarët federalë e monopolizuan detyrën për të zhvilluar paketat e testeve për virusin në duart e Qendrës për Kontrollin dhe Parandalimin e Sëmundjeve, duke përjashtuar nga këto përpjekje kompanitë private, gjë që ngadalësoi përgatitjen për identifikimin e rasteve. Paketat e para të testeve të zhvilluara nga Qendra për Kontrollin dhe Parandalimin e Sëmundjeve dolën difektoze.

Presidenti Trump shpenzoi disa javë duke ndryshuar zyrtarët dhe agjencitë që do të merrnin në dorë koordinimin e përgjigjes kundër koronavirusit. Ai emëroi Sekretarin Azar në krye të ekipit të Shtëpisë së Bardhë kundër koronavirusit, më pas, në fund të shkurtit, e zëvendësoi atë me Nënpresidentin Mike Pence. Ndërkohë që virusi vazhdonte të përhapej në mbarë botën, individë me peshë në Shtëpinë e Bardhë, përfshirë dhëndrrin e presidentit dhe këshilltar i tij i afërt, Jared Kushner dhe Sekretarin e Thesarit, Steven Mnuchin, i bënë thirrje presidentit të mos merrte masa radikale që do të trondisnin tregjet financiare.

Presidenti e kishte lidhur fatin e tij politik me ekonominë, me bursën. Vetëm kur çmimet e aksioneve ranë ndjeshëm presidenti reagoi me forcë. Në fund të shkurtit 2020, gjatë vizitës së presidentit në Indi, indeksi i bursës amerikane Dow Jones pësoi rënie të konsiderueshme ndërkohë që përhapej frika nga koronavirusi.

Presidenti dukej qartë i acaruar nga kjo rënie dhe gjatë udhëtimit për në SHBA më 26 shkurt 2020  reagoi ndaj komenteve të një zyrtareje të Qendrës për Kontrollin dhe Parandalimin e Sëmundjeve, Dr. Nancy Messonnier, e cila një ditë më pare kishte paralajmëruar amerikanët se duhet të përgatiteshin për distancim social dhe izolim mjaft të rëndë.

“Nuk bëhet fjalë nëse një gjë e tillë do të ndodhë, por kur do të ndodhë,” tha ekspertja.

Atë natë Presidenti Trump doli para amerikanëve me një konferencë për shtyp. Që nga ajo ditë, ajo ka zhvilluar konferenca të përditshme për shtyp.

Kur zhvilloi konferencën e parë për shtyp nga Shtëpia e Bardhë, Shtetet e Bashkuara kishin 15 pacientë të konfirmuar me koronavirus.

“Jemi në një nivel shumë të ulët; duam të vazhdojmë ta mbajmë kështu,” tha presidenti. “Jemi shumë, shumë të përgatitur”.

“Një herë 600 mijë apo 200 mijë”, reagon PD:Edi Rama gënjen, qeveria u dha ndihma vetëm 4 mijë familjeve në nevojë

Pas deklaratës së sotme të kryeministrit Edi Rama se nuk ka shqiptarë që vdesin për bukën e gojës dhe se po shpërndahen pako me ndihma për ta, vjen një reagim nga Partia Demokratike.



Përmes një mesazhi në Facebook, ish-deputetja Albana Vokshi iu kundërvu Ramës, ndërsa pohoi se ky i fundit gënjen. Ajo tha se në total, qeveria deri më tani ka shpërndarë 4 mijë pako për familjet në nevojë.




MESAZHI I  ALBANA VOKSHIT

Nuk ka asgjë për t’u besuar në ato që thotë Edi Rama. Faktet tregojnë se qeveria i ka braktisur njerëzit në skamje. Ata përdoren për të pozuar për facebookun e Edi Ramës dhe njëherë dalin 600 mijë, një herë 200 mijë, varet nga nevoja e çastit për propagandë. Fatkeqësisht, e vërteta nuk ka lidhje me ato që thotë Edi Rama dhe kopjet e tij më qeveri.

SHIKONI VIDEON 

 Dokumentat zyrtarë tregojnë se qeveria ka shpërndarë ushqime vetëm për 4 mijë familje në të gjithë vendin. Një skandal i vërtetë, po të llogarisësh milionat e eurove që shoërdorohen me koncesione dhe tendera sekretë korruptivë.